Bone Marrow TransplantationTransplantation, HomologousLiver TransplantationGraft vs Host DiseaseBone MarrowWhole-Body IrradiationBone Marrow CellsTransplantation ConditioningLeukemiaTransplantation, AutologousTissue DonorsGraft SurvivalAnemia, AplasticTransplantation ChimeraHematopoietic Stem Cell TransplantationBusulfanRecurrenceLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHistocompatibility TestingLeukocyte TransfusionHistocompatibilityGraft vs Tumor EffectImmunosuppressive AgentsGraft RejectionTreatment OutcomeTransplantation, IsogeneicHematologic NeoplasmsRadiation ChimeraLeukemia, Myeloid, AcuteGraft vs Host ReactionCyclophosphamidePrecursor Cell Lymphoblastic Leukemia-LymphomaRemission InductionLymphocyte DepletionKidney TransplantationTime FactorsImmunosuppressionGraft vs Leukemia EffectAcute DiseaseLiver DiseasesLiving DonorsTransplantation ImmunologyRetrospective StudiesHepatic Veno-Occlusive DiseaseLymphocyte TransfusionBone and BonesCombined Modality TherapyLiver FailureLeukemia, MyeloidCyclosporineMice, Inbred C57BLBone Marrow PurgingHematopoietic Stem CellsT-LymphocytesSurvival AnalysisChimeraMyelodysplastic SyndromesHematopoiesisNuclear FamilyActuarial AnalysisHeart TransplantationCytomegalovirus InfectionsSurvival RateStem Cell TransplantationHLA AntigensFatal OutcomeFollow-Up StudiesLiverLung TransplantationPostoperative ComplicationsHematologic DiseasesMice, Inbred BALB CLymphoma, Non-HodgkinSevere Combined ImmunodeficiencyTacrolimusCytarabineDisease-Free SurvivalOrgan TransplantationBone Marrow DiseasesAntineoplastic Combined Chemotherapy ProtocolsSpleenLiver NeoplasmsLiver CirrhosisPrognosisTissue and Organ ProcurementInfectionGranulocyte Colony-Stimulating FactorCyclosporinsPancytopeniaLeukocyte CountAntilymphocyte SerumLeukemia, Myelomonocytic, AcuteAnemia, Refractory, with Excess of BlastsSkin TransplantationTransplantation ToleranceTransplantationLymphomaEtoposideMethotrexateGanciclovir